COVID-19 and Epilepsy

The COVID19 pandemic is affecting all of us, regardless of where we are and what we do. Professionals in epilepsy, like most health professionals, are under substantial strain on many fronts. As clinicians, we are called to deliver care under difficult circumstances and often with limited or insufficient resources. As researchers, our clinical and basic research facilities are on lock down and programs are halted.

As the pandemic progresses, we learn more about the disease and the possible effect on our patients. Our model of care with regard to how we treat our patients has had to change. Here we provide up to date information and resources to help us do this.

If you have important information to share about management of people with epilepsy in relation to COVID-19, email us here

ILAE COVID-19 and Epilepsy Research Award

The ILAE wish to recognize research that has been undertaken during the COVID19 pandemic. The award, one to be awarded to the best research, published or in press, for each ILAE region, will consist of a certificate and a monetary award of $500. Preference will be given to more junior principal investigators. Applications to include the reference to be submitted to by 15th October 2021. Results will be announced in November 2021 in the ILAE newsletter, website and social media.

ILAE Congress Changes

The 34th International Epilepsy Congress will be held in August 2021 as originally planned.

All ILAE Regional Congresses have been postponed for this year. New dates will be available shortly.

We are actively preparing online education and the ILAE Academy will launch Q2 2020